Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon

Pali-Scholl, Isabella; DeBoer, Douglas J.; Alessandri, Claudia; Seida, Ahmed Adel; Müller, Ralf S. and Jensen-Jarolim, Erika (4. August 2020): Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon. In: Frontiers in Immunology, Vol. 11, 1697: pp. 1-8

Abstract

Allergen immunotherapy is currently the only causal treatment for allergic diseases in human beings and animals. It aims to re-direct the immune system into a tolerogenic or desensitized state. Requirements include clinical efficacy, safety, and schedules optimizing patient or owner compliance. To achieve these goals, specific allergens can be formulated with adjuvants that prolong tissue deposition and support uptake by antigen presenting cells, and/or provide a beneficial immunomodulatory action. Here, we depict adjuvant formulations being investigated for human and veterinary allergen immunotherapy.

• Item Type: Journal article
• Form of publication: Publisher's Version
• Keywords: Immunotherapy; adjuvant; allergy; allergen; veterinary; human
• Faculties: Veterinary Medicine
• Subjects: 600 Technology > 610 Medicine and health
• ISSN: 1664-3224
• Language: English